These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 1902133

  • 1. Modulation of vocal and nonvocal behavior in adult squirrel monkeys by selective MAO-A and MAO-B inhibition.
    Newman JD, Winslow JT, Murphy DL.
    Brain Res; 1991 Jan 04; 538(1):24-8. PubMed ID: 1902133
    [Abstract] [Full Text] [Related]

  • 2. Effect of long-term treatment with selective monoamine oxidase A and B inhibitors on dopamine release from rat striatum in vivo.
    Lamensdorf I, Youdim MB, Finberg JP.
    J Neurochem; 1996 Oct 04; 67(4):1532-9. PubMed ID: 8858937
    [Abstract] [Full Text] [Related]

  • 3. GABA-elevating effects of the antidepressant/antipanic drug phenelzine in brain: effects of pretreatment with tranylcypromine, (-)-deprenyl and clorgyline.
    Todd KG, Baker GB.
    J Affect Disord; 1995 Dec 13; 35(3):125-9. PubMed ID: 8749840
    [Abstract] [Full Text] [Related]

  • 4. Milacemide, a glycine pro-drug, inhibits strychnine-allodynia without affecting normal nociception in the rat.
    Khandwala H, Loomis CW.
    Pain; 1998 Jul 13; 77(1):87-95. PubMed ID: 9755023
    [Abstract] [Full Text] [Related]

  • 5. The novel neuropsychotropic agent milacemide is a specific enzyme-activated inhibitor of brain monoamine oxidase B.
    Janssens de Varebeke P, Pauwels G, Buyse C, David-Remacle M, De Mey J, Roba J, Youdim MB.
    J Neurochem; 1989 Oct 13; 53(4):1109-16. PubMed ID: 2769256
    [Abstract] [Full Text] [Related]

  • 6. Formation of the neurotransmitter glycine from the anticonvulsant milacemide is mediated by brain monoamine oxidase B.
    Janssens de Varebeke P, Cavalier R, David-Remacle M, Youdim MB.
    J Neurochem; 1988 Apr 13; 50(4):1011-6. PubMed ID: 3346666
    [Abstract] [Full Text] [Related]

  • 7. Thyroid iodide transport is reduced by administration of monoamine oxidase A inhibitors to rats.
    Cabanillas AM, Masini-Repiso AM, Costamagna ME, Pellizas C, Coleoni AH.
    J Endocrinol; 1994 Nov 13; 143(2):303-8. PubMed ID: 7829993
    [Abstract] [Full Text] [Related]

  • 8. Potentiation of para-hydroxyamphetamine-induced head-twitch response by inhibition of monoamine oxidase type A in the brain.
    Tadano T, Satoh S, Satoh N, Kisara K, Arai Y, Kim SK, Kinemuchi H.
    J Pharmacol Exp Ther; 1989 Jul 13; 250(1):254-60. PubMed ID: 2501477
    [Abstract] [Full Text] [Related]

  • 9. [Possible mechanism of selective inhibition of rat liver mitochondrial monoamine oxidase by chlorgiline and deprenyl].
    Severina IS.
    Biokhimiia; 1979 Feb 13; 44(2):195-207. PubMed ID: 435561
    [Abstract] [Full Text] [Related]

  • 10. Plasma 5-hydroxyindoleacetic acid as an indicator of monoamine oxidase-A inhibition in rat brain and peripheral tissues.
    Celada P, Artigas F.
    J Neurochem; 1993 Dec 13; 61(6):2191-8. PubMed ID: 7504085
    [Abstract] [Full Text] [Related]

  • 11. Properties of monoamine oxidase in monkey heart.
    Katayama M, Kobayashi S, Oguchi K, Yasuhara H.
    Jpn J Pharmacol; 1984 Aug 13; 35(4):425-31. PubMed ID: 6438377
    [Abstract] [Full Text] [Related]

  • 12. Monoamine oxidase substrates and substrate affinity.
    Domino EF.
    Schizophr Bull; 1980 Aug 13; 6(2):292-7. PubMed ID: 6769148
    [Abstract] [Full Text] [Related]

  • 13. Enhancement of rat brain cytosolic monoamine oxidase activity by clorgyline. Comparison with (-)-deprenyl and MDL 72145.
    Azam M, Jain S, Baquer NZ.
    Biochem Pharmacol; 1990 Nov 15; 40(10):2215-8. PubMed ID: 2123104
    [Abstract] [Full Text] [Related]

  • 14. Differential trace amine alterations in individuals receiving acetylenic inhibitors of MAO-A (clorgyline) or MAO-B (selegiline and pargyline).
    Murphy DL, Karoum F, Pickar D, Cohen RM, Lipper S, Mellow AM, Tariot PN, Sunderland T.
    J Neural Transm Suppl; 1998 Nov 15; 52():39-48. PubMed ID: 9564606
    [Abstract] [Full Text] [Related]

  • 15. Effects of monoamine oxidase inhibitors and dopamine agonists on the behavior of mammal- and frog-eating snakes.
    Temple JG, Barthalmus GT.
    Physiol Behav; 1994 May 15; 55(5):927-33. PubMed ID: 7912837
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of monoamine oxidase isoforms modulates nicotine withdrawal syndrome in the rat.
    Malin DH, Moon WD, Goyarzu P, Barclay E, Magallanes N, Vela AJ, Negrete AP, Mathews H, Stephens B, Mills WR.
    Life Sci; 2013 Oct 06; 93(12-14):448-53. PubMed ID: 23988853
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of MAO-A activity enhances behavioural activity of rats assessed using water maze and open arena tasks.
    Barbelivien A, Nyman L, Haapalinna A, Sirviö J.
    Pharmacol Toxicol; 2001 Jun 06; 88(6):304-12. PubMed ID: 11453370
    [Abstract] [Full Text] [Related]

  • 18. Effects of monoamine oxidase inhibitors on methamphetamine-induced stereotypy in mice and rats.
    Tatsuta T, Kitanaka N, Kitanaka J, Morita Y, Takemura M.
    Neurochem Res; 2005 Nov 06; 30(11):1377-85. PubMed ID: 16341934
    [Abstract] [Full Text] [Related]

  • 19. A comparison of drug-seeking behavior maintained by D-amphetamine, L-deprenyl (selegiline), and D-deprenyl under a second-order schedule in squirrel monkeys.
    Yasar S, Gaál J, Panlilio LV, Justinova Z, Molnár SV, Redhi GH, Schindler CW.
    Psychopharmacology (Berl); 2006 Jan 06; 183(4):413-21. PubMed ID: 16292593
    [Abstract] [Full Text] [Related]

  • 20. [Effect of solubilization by methylethylketone of rat liver mitochondrial monoamine oxidase on inhibition by clorgyline and deprenyl of the enzyme activity].
    Severina IS, Klimova GI, Nersisian AA.
    Biokhimiia; 1981 Nov 06; 46(11):2043-55. PubMed ID: 6797482
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.